Portfolio companies for the Curevc
Triton Therapeutics is a clinical stage company developing first-in-class medicines targeted at autoimmune and fibrotic diseases. Focus/Therapeutic Area: — Stage/Status: Clinical Website: https://www.tritonthera.com
Triton Therapeutics Read More »
Developing a novel antibody-enzyme fusion to target tumors and trigger the robust immune response known as hyper-acute rejection. By leveraging the natural power of the immune response system, we are able to utilize fusion protein technology to attack difficult tumor targets throughout the body. Focus/Therapeutic Area: Oncology Stage/Status: Seed Website: https://www.xenimmune.com
